Cargando…

Effects of Tafluprost on Ocular Blood Flow

Increasing evidence indicates that improving ocular blood flow (OBF) can be a therapeutic direction for glaucoma therapy. Tafluprost, a prostaglandin analogue which lowers the intraocular pressure (IOP), has been shown to improve OBF in animals and humans. Several animal experiments showed that topi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xinyue, Zhou, Xiaoyu, Zhao, Yang, Yang, Xiang, Zhou, Dengming, Chen, Baihua, Duan, Xuanchu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587142/ https://www.ncbi.nlm.nih.gov/pubmed/36109465 http://dx.doi.org/10.1007/s40123-022-00566-z

Ejemplares similares

A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications
por: Zhou, Xiaoyu, et al.
Publicado: (2022)

Construction of miRNA-mRNA regulatory network indicates potential biomarkers for primary open-angle glaucoma
por: Zhou, Xiaoyu, et al.
Publicado: (2023)

Analysis of the Responsiveness of Latanoprost, Travoprost, Bimatoprost, and Tafluprost in the Treatment of OAG/OHT Patients
por: Cai, Ziyan, et al.
Publicado: (2021)

Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension
por: Schultz, Clyde
Publicado: (2011)

Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
por: Ruangvaravate, Ngamkae, et al.
Publicado: (2020)

Differential pharmacology and clinical utility of preservative-free tafluprost in the treatment of ocular hypertension and glaucoma
por: Ermiş, Sıtkı Samet
Publicado: (2012)

Prevalence and diagnostic ability of β-zone parapapillary atrophy in open-angle glaucoma: a systematic review and meta-analysis
por: Zhou, Dengming, et al.
Publicado: (2022)

Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension
por: Lanzl, Ines, et al.
Publicado: (2013)

Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
por: Pozarowska, Dorota
Publicado: (2010)

Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
por: Tokuda, Naoto, et al.
Publicado: (2017)

Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension
por: Aihara, Makoto
Publicado: (2010)

Ocular Surface Cytotoxicity and Safety Evaluation of Tafluprost, a Recently Developed Anti-Glaucoma Prostaglandin Analog
por: Niwano, Yoshimi, et al.
Publicado: (2014)

Ocular Tolerability of Preservative-Free Tafluprost and Latanoprost: in vitro and in vivo Comparative Study
por: Esaki, Yoshihiko, et al.
Publicado: (2016)

Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China
por: Sun, Xinghuai, et al.
Publicado: (2022)

The potential role of long noncoding RNAs in primary open-angle glaucoma
por: Zhang, Feng, et al.
Publicado: (2021)

Fixed-Dose Combination of Tafluprost and Timolol in the Treatment of Open-Angle Glaucoma and Ocular Hypertension: Comparison with Other Fixed-Combination Products
por: Holló, Gábor, et al.
Publicado: (2014)

Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma
por: Liu, Yang, et al.
Publicado: (2013)

Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
por: Zhang, Feng, et al.
Publicado: (2019)

Efficacy and Safety of Switching from Tafluprost to a Tafluprost/Timolol Fixed Combination in Patients With Primary Open-Angle Glaucoma
por: Inoue, Kenji, et al.
Publicado: (2018)

Elevated IOP Alters the Material Properties of Sclera and Lamina Cribrosa in Monkeys
por: Jia, Xu, et al.
Publicado: (2022)

Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients
por: El Hajj Moussa, Wissam Georges, et al.
Publicado: (2018)

Ocular Blood Flow Autoregulation Mechanisms and Methods
por: Luo, Xue, et al.
Publicado: (2015)

Evaluating ocular blood flow
por: Maram, Jyotsna, et al.
Publicado: (2017)

Comparison of Ocular Pulse Amplitude Lowering Effects of Preservative-Free Tafluprost and Preservative-Free Dorzolamide-Timolol Fixed Combination Eyedrops
por: Seo, Du Ri, et al.
Publicado: (2015)

Retinal Blood Flow Velocity Change in Parafoveal Capillary after Topical Tafluprost Treatment in Eyes with Primary Open-angle Glaucoma
por: Iida, Yuto, et al.
Publicado: (2017)

The clinical effectiveness of tafluprost on Japanese normal-tension glaucoma patients
por: Nomura, Akio, et al.
Publicado: (2018)

Retinitis pigmentosa and ocular blood flow
por: Konieczka, Katarzyna, et al.
Publicado: (2012)

The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study
por: Okumichi, Hideaki, et al.
Publicado: (2017)

Effect of Ocular Dominance on Ocular Blood Flow Parameters
por: Nakaniida, Yuta, et al.
Publicado: (2023)

Gender Differences in Ocular Blood Flow
por: Schmidl, Doreen, et al.
Publicado: (2015)

Research Progress and Potential Applications of Spermidine in Ocular Diseases
por: Han, Wentao, et al.
Publicado: (2022)

Effects of tafluprost treatment for 3 years in patients with normal-tension glaucoma
por: Inoue, Kenji, et al.
Publicado: (2013)

A Pooled Assessment of Ocular Surface Disease After Switching from Preserved Prostaglandins to Tafluprost Across Six Countries in Asia
por: Tumbocon, Joseph Anthony, et al.
Publicado: (2022)

Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
por: Oddone, Francesco, et al.
Publicado: (2020)

Role of ocular blood flow in normal tension glaucoma
por: Wu, Xingdi, et al.
Publicado: (2022)

Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
por: Tang, Wenquan, et al.
Publicado: (2019)

Ocular Blood Flow and Normal Tension Glaucoma
por: Fan, Ning, et al.
Publicado: (2015)

Switching from concomitant therapy to tafluprost/timolol fixed combination
por: Inoue, Kenji, et al.
Publicado: (2018)

A Novel Convergent Synthesis of the Potent Antiglaucoma Agent Tafluprost
por: Krupa, Małgorzata, et al.
Publicado: (2017)

Efficacy and safety of the fixed combinations of tafluprost/timolol and latanoprost/carteolol
por: Fuwa, Masahiro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mjdcht7f5auqt9lu03caei5gv9